Gene: PDIA5
Official Full Name: protein disulfide isomerase family A member 5provided by HGNC
Gene Summary: This gene encodes a member of the disulfide isomerase (PDI) family of endoplasmic reticulum (ER) proteins that catalyze protein folding and thiol-disulfide interchange reactions. The encoded protein has an N-terminal ER-signal sequence, three catalytically active thioredoxin (TRX) domains, a TRX-like domain, and a C-terminal ER-retention sequence. The N-terminal TRX-like domain is the primary binding site for the major ER chaperone calreticulin and possibly other proteins and substrates as well. Alternative splicing results in multiple protein- and non-protein-coding transcript variants. [provided by RefSeq, Dec 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06432 | PDIA5 Knockout cell line (HeLa) | Human | PDIA5 | 1:3~1:6 | Negative | Online Inquiry |
KO06433 | PDIA5 Knockout cell line (HCT 116) | Human | PDIA5 | 1:2~1:4 | Negative | Online Inquiry |
KO06434 | PDIA5 Knockout cell line (HEK293) | Human | PDIA5 | 1:3~1:6 | Negative | Online Inquiry |
KO06435 | PDIA5 Knockout cell line (A549) | Human | PDIA5 | 1:3~1:4 | Negative | Online Inquiry |
PDIA5 Gene Knockout Cell Lines are specially engineered cellular models that disrupt the expression of the PDIA5 gene, which encodes a protein involved in protein folding and quality control within the endoplasmic reticulum. These knockout cell lines are invaluable tools for studying the role of PDIA5 in cellular stress responses and its implications in diseases like cancer and neurodegenerative disorders. By silencing PDIA5, researchers can observe the resultant effects on cell viability, apoptosis, and protein synthesis, providing insights into the molecular pathways that underpin these critical cellular processes.
The fundamental mechanism of action involves the systematic inactivation of PDIA5 through CRISPR/Cas9 technology or similar genetic engineering methods, ensuring a reliable and reproducible lack of the target protein. This allows for controlled experiments to assess the impacts of PDIA5 depletion on various cellular responses, offering a clear picture of its functional repertoire. The scientific importance of this product lies in its application across numerous fields, notably in pharmacology, molecular biology, and translational medicine, where it aids in understanding disease mechanisms and identifying potential therapeutic targets.
Compared to alternative cell lines that only exhibit partial gene knockdowns or utilize pharmacological inhibitors, PDIA5 Gene Knockout Cell Lines guarantee a complete reduction of PDIA5 expression. This specificity allows for more accurate data interpretation and greater validity in experimental designs. The potential to replicate the pathological states related to PDIA5 dysregulation presents a unique advantage to researchers focusing on cellular homeostasis and disease progression.
For researchers and clinicians alike, this product offers unparalleled value by enabling robust studies into the significance of PDIA5 in both health and disease contexts. Our commitment to advancing scientific knowledge is evident in the precision of our genetic engineering techniques and the comprehensive support provided with our products. With expertise in producing high-quality biological reagents, we aim to empower your research endeavors with PDIA5 Gene Knockout Cell Lines, ensuring reliable results in your scientific investigations.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.